Mark D. Walsh

502 total citations
8 papers, 390 citations indexed

About

Mark D. Walsh is a scholar working on Oncology, Biomaterials and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mark D. Walsh has authored 8 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Biomaterials and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mark D. Walsh's work include Nanoparticle-Based Drug Delivery (4 papers), Intraperitoneal and Appendiceal Malignancies (2 papers) and Cancer therapeutics and mechanisms (1 paper). Mark D. Walsh is often cited by papers focused on Nanoparticle-Based Drug Delivery (4 papers), Intraperitoneal and Appendiceal Malignancies (2 papers) and Cancer therapeutics and mechanisms (1 paper). Mark D. Walsh collaborates with scholars based in United States. Mark D. Walsh's co-authors include William C. Zamboni, Sumit Rawal, Warefta Hasan, Mary E. Napier, J. Christopher Luft, Joseph M. DeSimone, Arlene S. Bridges, Kevin S. Chu, Michael Kabat and David Jacobson‐Kram and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Mark D. Walsh

8 papers receiving 372 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark D. Walsh United States 5 148 105 105 81 69 8 390
Frédéric Bérenguer France 9 21 0.1× 69 0.7× 44 0.4× 49 0.6× 90 1.3× 10 368
Dimitri Kereselidze France 10 16 0.1× 26 0.2× 81 0.8× 90 1.1× 149 2.2× 35 408
В. Е. Иванов Russia 13 22 0.1× 13 0.1× 65 0.6× 86 1.1× 105 1.5× 30 459
Alia Al‐Ebraheem Canada 13 16 0.1× 22 0.2× 57 0.5× 74 0.9× 40 0.6× 23 361
Trudi Foreman United States 9 10 0.1× 11 0.1× 43 0.4× 64 0.8× 128 1.9× 12 437
Thèodorine Bailly France 14 11 0.1× 38 0.4× 10 0.1× 186 2.3× 62 0.9× 29 575
Emilija Janevik-Ivanovska North Macedonia 7 42 0.3× 27 0.3× 13 0.1× 141 1.7× 51 0.7× 23 350
Sinbad Sweeney United Kingdom 10 24 0.2× 15 0.1× 87 0.8× 5 0.1× 33 0.5× 10 349
S.V. Petrenko Belarus 10 82 0.6× 37 0.4× 35 0.3× 86 1.1× 19 0.3× 22 360
Agnieszka Panek Poland 12 45 0.3× 5 0.0× 65 0.6× 63 0.8× 105 1.5× 36 407

Countries citing papers authored by Mark D. Walsh

Since Specialization
Citations

This map shows the geographic impact of Mark D. Walsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Walsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Walsh more than expected).

Fields of papers citing papers by Mark D. Walsh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark D. Walsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Walsh. The network helps show where Mark D. Walsh may publish in the future.

Co-authorship network of co-authors of Mark D. Walsh

This figure shows the co-authorship network connecting the top 25 collaborators of Mark D. Walsh. A scholar is included among the top collaborators of Mark D. Walsh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark D. Walsh. Mark D. Walsh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Walsh, Mark D., et al.. (2022). Survey of biosimilar adoption across oncology pharmacy practices.. Journal of Clinical Oncology. 40(16_suppl). e18813–e18813. 1 indexed citations
2.
Giovinazzo, Hugh, Parag Kumar, Arif Sheikh, et al.. (2016). Technetium Tc 99m sulfur colloid phenotypic probe for the pharmacokinetics and pharmacodynamics of PEGylated liposomal doxorubicin in women with ovarian cancer. Cancer Chemotherapy and Pharmacology. 77(3). 565–573. 19 indexed citations
3.
Walsh, Mark D., et al.. (2013). Meta-analysis of inter-patient pharmacokinetic variability of liposomal and non-liposomal anticancer agents. Nanomedicine Nanotechnology Biology and Medicine. 10(1). 109–117. 38 indexed citations
4.
Chu, Kevin S., Warefta Hasan, Sumit Rawal, et al.. (2012). Plasma, tumor and tissue pharmacokinetics of Docetaxel delivered via nanoparticles of different sizes and shapes in mice bearing SKOV-3 human ovarian carcinoma xenograft. Nanomedicine Nanotechnology Biology and Medicine. 9(5). 686–693. 127 indexed citations
5.
Walsh, Mark D., Suzan K. Hanna, Sumit Rawal, et al.. (2012). Pharmacokinetics and Antitumor Efficacy of XMT-1001, a Novel, Polymeric Topoisomerase I Inhibitor, in Mice Bearing HT-29 Human Colon Carcinoma Xenografts. Clinical Cancer Research. 18(9). 2591–2602. 29 indexed citations
6.
7.
8.
McDiarmid, Melissa A., James P. Keogh, Frank J. Hooper, et al.. (2000). Health Effects of Depleted Uranium on Exposed Gulf War Veterans. Environmental Research. 82(2). 168–180. 173 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frédéric Bérenguer Breakdown of academic impact, for papers by Dimitri Kereselidze Breakdown of academic impact, for papers by В. Е. Иванов Breakdown of academic impact, for papers by Alia Al‐Ebraheem Breakdown of academic impact, for papers by Trudi Foreman Breakdown of academic impact, for papers by Thèodorine Bailly Breakdown of academic impact, for papers by Emilija Janevik-Ivanovska Breakdown of academic impact, for papers by Sinbad Sweeney Breakdown of academic impact, for papers by S.V. Petrenko Breakdown of academic impact, for papers by Agnieszka Panek
Rankless by CCL
2026